Commentary: Effect of fecal microbiota transplantation on non-alcoholic fatty liver disease: A randomized clinical trial
Main Authors: | Jieyi Wang, Jinhan Chen, Mingxian Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.1056394/full |
Similar Items
-
Fecal microbiota transplantation—could stool donors’ and receptors’ diet be the key to future success?
by: Rita Silva, et al.
Published: (2023-11-01) -
Fecal microbiota transfer to treat ulcerative colitis: Medical and legal challenges
by: Arndt Steube, et al.
Published: (2023-03-01) -
Effect of Fecal Microbiota Transplantation on Non-Alcoholic Fatty Liver Disease: A Randomized Clinical Trial
by: Lanfeng Xue, et al.
Published: (2022-07-01) -
Antitumor effects of fecal microbiota transplantation: Implications for microbiome modulation in cancer treatment
by: Hui Xu, et al.
Published: (2022-09-01) -
From Donor to Patient: Collection, Preparation and Cryopreservation of Fecal Samples for Fecal Microbiota Transplantation
by: Carole Nicco, et al.
Published: (2020-04-01)